Weinreb Mark 4

Accession 0001567619-19-007663

CIK 0001505497other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 5:21 PM ET

Size

46.6 KB

Accession

0001567619-19-007663

Insider Transaction Report

Form 4

Period: 2019-03-25

BioRestorative Therapies, Inc.BRTX

Weinreb Mark

DirectorCEO and Chairman of the Board10% Owner

Transactions

Award
Stock Option
2019-03-25+275,000→ 275,000 total
Exercise: $0.75Exp: 2027-06-23→ Common Stock (275,000 underlying)
Award
Stock Option
2019-03-25+275,000→ 275,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (275,000 underlying)
Award
Stock Option
2019-03-25+275,000→ 275,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (275,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−12,500→ 0 total
Exercise: $4.70Exp: 2023-10-04→ Common Stock (12,500 underlying)
Award
Stock Option
2019-03-25+50,000→ 50,000 total
Exercise: $0.75Exp: 2024-02-18→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−50,000→ 0 total
Exercise: $4.70Exp: 2022-02-09→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−208,000→ 0 total
Exercise: $4.70Exp: 2025-09-04→ Common Stock (208,000 underlying)
Award
Stock Option
2019-03-25+150,000→ 150,000 total
Exercise: $0.75Exp: 2024-10-23→ Common Stock (150,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−275,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (275,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−275,000→ 0 total
Exercise: $3.35Exp: 2027-06-23→ Common Stock (275,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−275,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (275,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−4,000→ 0 total
Exercise: $4.70From: 2010-12-15Exp: 2020-12-14→ Common Stock (4,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−20,000→ 0 total
Exercise: $4.70Exp: 2022-12-07→ Common Stock (20,000 underlying)
Award
Stock Option
2019-03-25+12,500→ 12,500 total
Exercise: $0.75Exp: 2023-10-04→ Common Stock (12,500 underlying)
Award
Stock Option
2019-03-25+208,000→ 208,000 total
Exercise: $0.75Exp: 2025-09-04→ Common Stock (208,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−50,000→ 0 total
Exercise: $4.70Exp: 2024-02-18→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−150,000→ 0 total
Exercise: $4.70Exp: 2024-10-23→ Common Stock (150,000 underlying)
Award
Stock Option
2019-03-25+4,000→ 4,000 total
Exercise: $0.75From: 2010-12-15Exp: 2020-12-14→ Common Stock (4,000 underlying)
Award
Stock Option
2019-03-25+50,000→ 50,000 total
Exercise: $0.75Exp: 2022-02-09→ Common Stock (50,000 underlying)
Award
Stock Option
2019-03-25+20,000→ 20,000 total
Exercise: $0.75Exp: 2022-12-07→ Common Stock (20,000 underlying)

Holdings

Common Stock
80,000

Footnotes (10)

[F1]The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014.
[F10]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.
[F2]The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013.
[F3]The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
[F4]The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016.
[F5]The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
[F6]The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018.
[F7]The option is exercisable to the extent of 91,667 shares on each of June 10, 2016 and June 10, 2017, and 91,666 shares on June 10, 2018.
[F8]The option is exercisable to the extent of 91,667 shares on each of June 23, 2017 and June 23, 2018, and 91,666 shares on June 23, 2019.
[F9]The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

→

Entity typeother

Related Parties

filerCIK 0001527212

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 5:21 PM ET
Size: 46.6 KB

View on SEC.gov